Strong finish with a big buy in the after market, sell side has thinned out quite a bit as well. Looks primed for a run to retest .97-1.0
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress